ATE206926T1 - Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne - Google Patents
Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akneInfo
- Publication number
- ATE206926T1 ATE206926T1 AT97112984T AT97112984T ATE206926T1 AT E206926 T1 ATE206926 T1 AT E206926T1 AT 97112984 T AT97112984 T AT 97112984T AT 97112984 T AT97112984 T AT 97112984T AT E206926 T1 ATE206926 T1 AT E206926T1
- Authority
- AT
- Austria
- Prior art keywords
- acne
- producing
- treatment
- phosphoric acid
- acid diester
- Prior art date
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title abstract 2
- 206010000496 acne Diseases 0.000 title abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- -1 diester compound Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20090096 | 1996-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE206926T1 true ATE206926T1 (de) | 2001-11-15 |
Family
ID=16432133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97112984T ATE206926T1 (de) | 1996-07-31 | 1997-07-29 | Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5807845A (de) |
| EP (1) | EP0821962B1 (de) |
| AT (1) | ATE206926T1 (de) |
| CA (1) | CA2209690A1 (de) |
| DE (1) | DE69707372T2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| CN1262274C (zh) * | 2000-11-14 | 2006-07-05 | 生命健康科学有限公司 | 磷酸盐衍生物复合物 |
| BR0211673A (pt) * | 2001-07-27 | 2004-07-13 | Vital Health Sciences Pty Ltd | Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons |
| ATE487456T1 (de) * | 2001-12-13 | 2010-11-15 | Vital Health Sciences Pty Ltd | Transdermaler transport von verbindungen |
| AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| CA2513427C (en) * | 2003-01-17 | 2012-03-27 | Vital Health Sciences Pty Ltd. | Compounds having anti-proliferative properties |
| AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
| ATE495730T1 (de) | 2004-03-03 | 2011-02-15 | Vital Health Sciences Pty Ltd | Alkaloid-formulierungen |
| MX2007010492A (es) * | 2005-03-03 | 2007-11-08 | Vital Health Sciences Pty Ltd | Compuestos que tienen propiedades anticancer. |
| EP2548581A3 (de) * | 2005-06-17 | 2013-02-20 | Vital Health Sciences Pty Ltd. | Träger mit einem oder mehreren Di- bzw. Mono-(Elektrontransfermittel) Phosphatderivaten oder Komplexen davon |
| WO2007070981A1 (en) * | 2005-12-23 | 2007-06-28 | Vital Health Sciences Pty Ltd | Compounds having cytokine modulating properties |
| AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| MX2012011355A (es) | 2010-03-30 | 2012-11-30 | Phosphagenics Ltd | Parche de suministro transdermico. |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| CN114712308A (zh) | 2015-12-09 | 2022-07-08 | 磷肌酸有限公司 | 药物制剂 |
| EP3558903B1 (de) | 2016-12-21 | 2024-07-03 | Avecho Biotechnology Limited | Verfahren zur phosphorylierung eines komplexen alkohols |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59219295A (ja) * | 1983-05-30 | 1984-12-10 | Senjiyu Seiyaku Kk | リン酸ジエステルまたはその塩およびそれらの製造法 |
| JPH0781138B2 (ja) * | 1986-12-02 | 1995-08-30 | 株式会社資生堂 | 抗酸化剤 |
| DE4328871A1 (de) * | 1993-08-27 | 1995-03-02 | Beiersdorf Ag | Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis |
| FR2715565B1 (fr) * | 1994-01-31 | 1996-03-15 | Oreal | Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation. |
| TW287103B (de) * | 1994-04-22 | 1996-10-01 | Senju Pharma Co |
-
1997
- 1997-07-07 CA CA002209690A patent/CA2209690A1/en not_active Abandoned
- 1997-07-29 US US08/903,036 patent/US5807845A/en not_active Expired - Lifetime
- 1997-07-29 EP EP97112984A patent/EP0821962B1/de not_active Expired - Lifetime
- 1997-07-29 DE DE69707372T patent/DE69707372T2/de not_active Expired - Lifetime
- 1997-07-29 AT AT97112984T patent/ATE206926T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0821962A1 (de) | 1998-02-04 |
| DE69707372D1 (de) | 2001-11-22 |
| CA2209690A1 (en) | 1998-01-31 |
| DE69707372T2 (de) | 2002-04-25 |
| US5807845A (en) | 1998-09-15 |
| EP0821962B1 (de) | 2001-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE206926T1 (de) | Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne | |
| HU9600834D0 (en) | Quinazoline derivatives | |
| DE69310065D1 (de) | Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose | |
| IL120584A (en) | 1,2-diphenylpyrrole derivatives, use thereof for the manufacture of a medicament and pharmaceutical compositions containing the same | |
| ATE173626T1 (de) | Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis | |
| ATE141508T1 (de) | Zusammensetzung zur förderung des lipidmetabolismus | |
| ATE205712T1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der angiogenese und angiogene krankheiten | |
| ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
| ATE181237T1 (de) | Substituierte cyclohexan-derivate zur behandlung von krankheiten | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| ATE123944T1 (de) | Verwendung von trifluormethylphenyl- tetrahydropyridinen zur herstellung von arzneimitteln zur behandlung anxio-depressiver erkrankungen. | |
| FI102896B1 (fi) | Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi | |
| ATE156359T1 (de) | Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis | |
| DE69413118D1 (de) | Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität | |
| DE3873578D1 (de) | Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| DE69418744D1 (de) | Verwendung von Pregnanderivaten zur Behandlung von Tumoren | |
| ATE284684T1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
| DE69917668D1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ITMI920082A1 (it) | Derivati solforati di acidi biliari | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| IL110369A0 (en) | Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |